Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06511999 · ClinicalTrials.gov registry record
Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest
A clinical trial of Cardiac Arrest, sponsored by Byron Drumheller.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT06511999: Recruiting study of Cardiac Arrest, sponsored by Byron Drumheller.
NCT06511999 is a study of Cardiac Arrest that is actively recruiting participants, run by Byron Drumheller. The registered enrollment target is 25 participants, below the 1,479-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06511999, a study of Cardiac Arrest, is actively recruiting participants, sponsored by Byron Drumheller.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients successfully resuscitated from sudden cardiac arrest are often comatose, having suffered a period of low blood flow and oxygen delivery to the brain. They are also at risk of suffering further brain injury during the immediate period after resuscitation, in which the brain's normal regulatory functions are impaired. To diagnose and treat secondary brain injury in comatose patients after cardiac arrest, doctors use a variety of neurological monitoring techniques. One of these methods involves measuring the oxygen saturation of blood going into and out of the brain to determine whether the brain is receiving and utilizing oxygen in an optimal manner. The oxygen saturation of blood exiting the brain is called the jugular venous oxygen saturation (SjO2). It is measured by inserting a catheter into the jugular vein in the neck and sampling blood as it exits the skull. The blood sample is sent to the hospital laboratory and the oxygen saturation is measured on a blood gas machine. This method of SjO2 measurement has limitations, particularly that blood must be taken out of the patient and sent to the lab for analysis, which can only be done feasibly every few hours. Special catheters exist that can measure the oxygen saturation of blood passing by the tip of the catheter inside the patient on a second-by-second basis, without needing to withdraw blood and send it to the laboratory. With such rapidly available data, doctors may be able to better diagnose and treat brain oxygen abnormalities in post cardiac arrest patients. In this study, the investigators plan to determine the accuracy of an existing, Food and Drug Administration (FDA)-cleared catheter capable of continuous, indwelling measurement of venous blood oxygen saturation for SjO2 monitoring in comatose patients early after cardiac arrest. The SjO2 measurements from the study catheter will be compared with standard SjO2 measurements made by withdrawing blood and analyzing it in the laboratory to determin
Primary Outcome
The accuracy of SjO2 measurement with the PediaSat Oximetry Catheter will be determined by comparing the SjO2 measurements obtained from the study catheter with the gold standard of SjO2 measured on jugular venous blood simultaneously withdrawn from the catheter and analyzed on a blood gas machine. Each participant will have \~10-15 paired SjO2 measurements. The Bland-Altman method for assessing agreement between two methods of clinical measurement with multiple observations per participant will
Conditions Studied
Interventions
- DEVICE Continuous SjO2 monitoring with a PediaSat Oximetry Catheter
- DIAGNOSTIC_TEST Intermittent SjO2 monitoring with a PediaSat Oximetry Catheter
Study Locations (1)
Pennsylvania
- UPMC Presbyterian Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-09-20 |
| Est. Completion | 2027-12-31 |
What NCT06511999 shows while recruiting
NCT06511999 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,479-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Cardiac Arrest appearing as the primary indexed condition, and to 2 interventions - of which Continuous SjO2 monitoring with a PediaSat Oximetry Catheter is the first listed.
NCT06511999 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06511999 about?
NCT06511999 is a clinical study titled "Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest". Patients successfully resuscitated from sudden cardiac arrest are often comatose, having suffered a period of low blood flow and oxygen delivery to the brain. They are also at risk of suffering further brain injury during the immediate period after resuscitation, in which the brain's normal regulato...
What is the current status of trial NCT06511999?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2025-09-20. Estimated completion is 2027-12-31.
What conditions does trial NCT06511999 study?
This clinical trial studies the following conditions: Cardiac Arrest.
What interventions are being tested in trial NCT06511999?
The interventions under investigation include: Continuous SjO2 monitoring with a PediaSat Oximetry Catheter (DEVICE), Intermittent SjO2 monitoring with a PediaSat Oximetry Catheter (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06511999?
This trial is sponsored by Byron Drumheller, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06511999 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06511999's enrollment target sits among peer trials
25 26th of 31 higher than 6 of 31 other Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Amiodarone in Shockable Cardiac Arrest
RECRUITING · Phase 3
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Post-CA Neuroprotection With Magnesium
RECRUITING · Phase 1
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI